Received: 7 December 2019
Accepted: 25 May 2020
First Online: 8 July 2020
Ethics approval and consent to participate
: Although there is no ethical issue in reporting of this case, ethical approval from the appropriate ethical committee is provided.
: Written informed consent was obtained from the patient’s legal guardian (his father) for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: The authors declare that they have no competing interests in any part from the treatment process to writing the manuscript. The chemotherapy agent – mitotane – may raise suspicion of conflict of interest, but we declare we have no conflict of interest with the company producing this medication, and this medication is the standard of treatment in this case and its use is inevitable.